LGI1 and acrodermatitis enteropathica: N-Methyl-d-aspartate receptor (NMDAR) and leucine-rich glioma-inactivated 1 (LGI1) antibodies define the most prevalently recognised AE syndromes, and will be the primary focus of this review (Table 1).